awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38085691-1B33817B-7BC2-4CFE-B582-46997A8CC7CC
Q38085691-1B33817B-7BC2-4CFE-B582-46997A8CC7CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38085691-1B33817B-7BC2-4CFE-B582-46997A8CC7CC
Differentiating sodium-glucose co-transporter-2 inhibitors in development for the treatment of type 2 diabetes mellitus.
P2860
Q38085691-1B33817B-7BC2-4CFE-B582-46997A8CC7CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38085691-1B33817B-7BC2-4CFE-B582-46997A8CC7CC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9de074a87bfb0df2d85d0c9395f22520b9ad2b3d
P2860
Single-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy volunteers and patients with type 2 diabetes mellitus.